Executive Summary

Oct 2019
PROSPECTS
Static prices for adult analgesics due to generics, while parents continue to place trust in known brands for children

Analgesics continued to record low positive current value growth in 2019 in Ireland, with many local consumers persuaded to turn to generics over the review period; with a perceived lack of innovation, some consumers saw little difference between brands and their generic counterparts, particularly within adult analgesics. However, while unit prices of adult analgesics are set to remain static over the forecast period, despite strong loyalty towards leading brands such as Panadol and Nurofen which benefit from strong consumer trust in global names, paediatric analgesics will experience a gradual rise in prices, as Irish parents will continue to purchase known brands such as Calpol, rather than choose generics for their children.

Waning interest in aspirin and combination products

Adult analgesics will continue to record stable demand over the forecast period with acetaminophen and ibuprofen continuing to enjoy a growing preference amongst local consumers, mainly due to habit and strong loyalty associated with brands such as Panadol. Consumers’ busier and more stressful lifestyles will encourage them to seek pain relief from tension headaches and muscle pain through the use of known and trusted analgesics.

Topical analgesics/anaesthetic will continue to gain in popularity due to direct targeting of problem

The niche of topical analgesics/anaesthetic will continue to gain in popularity over the forecast period, with the safety of some types of pain relief being further called into questioned going forward, as some consumers only opt for pain relief as a very last resort. Therefore, some consumers prefer to target pain relief directly rather than ingesting pills.

COMPETITIVE LANDSCAPE
GSK Consumer Healthcare takes over leadership following merger with Pfizer

GSK Consumer Healthcare took over the leadership of overall analgesics in 2019, following a tie-up between GlaxoSmithKline and US rival Pfizer Inc, merging their consumer health divisions. GSK Consumer Healthcare now owns former Pfizer brands such as Tramil and Anadin, in addition to retaining its own lines including Voltarol and Panadol.

Irish player launches new acetaminophen

Analgesics continued to experience limited innovation, with leading brands consolidating their positions to compete against their generic counterparts, increasing their advertising in the hope of attracting consumers through their global reputations. However, one new launch was witnessed by Irish company Rowa Pharmaceuticals Ltd, known more for its presence in haemorrhoid treatments.

Calpol continues to enjoy strong brand loyalty amongst Irish parents

Paediatric analgesics continued to be led by acetaminophen brand Calpol from McNeil Healthcare (Ireland) Ltd, which strengthened its position with a varied range of products including its infant line. Irish parents place a great deal of trust in known names for their children and therefore Calpol continues to enjoy consumer loyalty.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Ireland

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Ireland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Ireland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Ireland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Ireland?
  • What are the major brands in Ireland?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Ireland - Category analysis

HEADLINES

PROSPECTS

Static prices for adult analgesics due to generics, while parents continue to place trust in known brands for children
Waning interest in aspirin and combination products
Topical analgesics/anaesthetic will continue to gain in popularity due to direct targeting of problem

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare takes over leadership following merger with Pfizer
Irish player launches new acetaminophen
Calpol continues to enjoy strong brand loyalty amongst Irish parents

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Ireland - Industry Overview

EXECUTIVE SUMMARY

Ongoing stable demand for consumer health in Ireland supported by polarised consumer groups
Growing interest in vegetarian and vegan lifestyles supports demand for alternative sources of protein
Global players continue to lead consumer health
Internet retailing continues to gain ground as distribution channel
Positive performance for consumer health predicted although several negative factors could impact demand for certain products

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources